Results 1 to 10 of about 1,813,298 (197)

Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting

Biomedicines, 2023
High lipoprotein(a) (Lp(a)) plasma levels are significantly associated with an increased risk of developing atherosclerotic cardiovascular diseases (ASCVD).
Arrigo F. G. Cicero, Federica Fogacci, Marina Giovannini, Elisa Grandi, Sergio D’Addato, Claudio Borghi   +5 more
doaj   +1 more source

Comparative effect of a nutraceutical compound based on a flavonoid complex from bergamot on plasma lipids, glucose metabolism, and liver enzymes: a 3-arm, double-blind, placebo-controlled, randomized clinical trial

Archives of Medical Science, 2022
Introduction Bergamot and opuntia (prickly pear cladodes) standardized extracts have been demonstrated to have positive metabolic effects in preclinical and clinical models. Material and methods The aim of this study was to evaluate the metabolic effect
Federica Fogacci, Valentina Di Micoli, Maddalena Veronesi, Arrigo F.G. Cicero   +3 more
doaj   +1 more source

Sudden Fall in the Lipid-Lowering Effect of Evolocumab: The Butler Is Not Always Guilty

Medicina, 2021
A 78-year-old man came to our attention after undergoing coronary computed tomography angiography documenting multivessel coronary artery disease. He was started on treatment with the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor ...
Federica Fogacci, Claudio Borghi, Antonio Di Micoli, Arrigo F. G. Cicero   +3 more
doaj   +1 more source

Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study

Biomedicines, 2022
In the last decades, high serum levels of lipoprotein(a) (Lp(a)) have been associated with increased cardiovascular disease (CVD) risk, in particular among individuals with smaller apolipoprotein(a) (apo(a)) isoforms than those with larger sizes. The aim
Arrigo F. G. Cicero, Federica Fogacci, Giuseppe Derosa, Angela D’Angelo, Fulvio Ventura, Elisabetta Rizzoli, Sergio D’Addato, Claudio Borghi, on behalf of the Brisighella Heart Study Group   +8 more
doaj   +1 more source

Efficacy and safety of inclisiran a newly approved FDA drug: a systematic review and pooled analysis of available clinical studies

American Heart Journal Plus, 2022
Study objective: This systematic review and meta-analysis aimed to assess the efficacy and safety profile of treatment with inclisiran, a drug that has been recently approved by the United States Food and Drug Administration (FDA) and the European ...
Arrigo F.G. Cicero, Federica Fogacci, Alberto Zambon, Peter P. Toth, Claudio Borghi   +4 more
doaj   +1 more source

Cardiovascular risk factors [PDF]

Medical Journal of Australia, 1988
R, Carbon, P, Fricker, K, Maguire
  +15 more sources

Cardiovascular risk and cardiovascular risk factors in adolescents

Revista Brasileira de Enfermagem, 2022
ABSTRACT Objectives: to identify cardiovascular risk and cardiovascular risk factors in adolescents and verify correlations between these variables and biochemical markers, and between blood pressure percentiles, Body Mass Index, and biochemical markers. Methods: a cross-sectional study, conducted at a Brazilian school, from August to September 2019,
Emilia Soares Chaves Rouberte, Thelma Leite de Araujo, Daniel Freire de Sousa, Daiany Maria Castro Nogueira, Rebecca Silveira Maia, Rafaella Pessoa Moreira, Ederson Laurindo Holanda de Sousa, Livia Mara Bezerra Pinto   +7 more
openaire   +3 more sources

Cardiovascular diseases: Risk factors [PDF]

Medicinski casopis, 2016
Objective. The aim of this study was to investigate the prevalence and impact of certain risk factors for cardiovascular diseases. Methods. Observational cross-sectional study was conducted in the Health Centre of Kragujevac, in 2014. In total, 98 people older than 35 years, with no previous diagnosis of cardiovascular diseases were chosen by simple ...
Stajic, Dalibor, Djonović, Nela
openaire   +2 more sources

Cardiovascular Risk Factors [PDF]

Circulation: Cardiovascular Genetics, 2012
The following articles are being highlighted as part of Circulation: Cardiovascular Genetics ’ Topic Review series. This series will summarize the most important manuscripts, as selected by the editors, published in the Circulation portfolio and
  +5 more sources

Non-Conventional Risk Factors: “Fact” or “Fake” in Cardiovascular Disease Prevention?

Biomedicines, 2023
Cardiovascular diseases (CVDs), such as arterial hypertension, myocardial infarction, stroke, heart failure, atrial fibrillation, etc., still represent the main cause of morbidity and mortality worldwide.
Giovanni Cimmino, Francesco Natale, Roberta Alfieri, Luigi Cante, Simona Covino, Rosa Franzese, Mirella Limatola, Luigi Marotta, Riccardo Molinari, Noemi Mollo, Francesco S Loffredo, Paolo Golino   +11 more
doaj   +1 more source